First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses.
Andrews JPM, Joshi SS, Tzolos E, Syed MB, Cuthbert H, Crica LE, Lozano N, Okwelogu E, Raftis JB, Bruce L, Poland CA, Duffin R, Fokkens PHB, Boere AJF, Leseman DLAC, Megson IL, Whitfield PD, Ziegler K, Tammireddy S, Hadjidemetriou M, Bussy C, Cassee FR, Newby DE, Kostarelos K, Miller MR.
Andrews JPM, et al. Among authors: fokkens phb.
Nat Nanotechnol. 2024 May;19(5):705-714. doi: 10.1038/s41565-023-01572-3. Epub 2024 Feb 16.
Nat Nanotechnol. 2024.
PMID: 38366225
Clinical Trial.